Inventor
RUIJTENBEEK ROBBY
NL9 patents
⚠️ This page may combine multiple inventors who share the name “RUIJTENBEEK ROBBY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PAMGENE BV
3 patentsUS12545946B2Feb 10, 2026
Method for predicting the response of melanoma patients to a medicament
PAMGENE BV0 citations38
US11802315B2Oct 31, 2023
Method for predicting the response of non-small-cell lung carcinoma patients to a medicament
PAMGENE BV0 citations37
US10604786B2Mar 31, 2020
Method for predicting the response of melanoma patients to targeted pharmacotherapy
PAMGENE BV0 citations30
RUIJTENBEEK ROBBY
3 patentsUS9448237B2Sep 20, 2016
Modified tyrosine amino acids, peptides containing them, and their use for detecting hydrolase enzyme activity
RUIJTENBEEK ROBBY0 citations37
US9075061B2Jul 7, 2015
Method for determining the estrogen receptor status of breast cancer
RUIJTENBEEK ROBBY0 citations34
US9128087B2Sep 8, 2015
Nuclear receptor assay
RUIJTENBEEK ROBBY0 citations33
DE WIJN RICHARD
2 patentsUS8962267B1Feb 24, 2015
Method for predicting the response of non-small cell lung cancer patients to targeted pharmacotherapy
DE WIJN RICHARD8 citations72
US8962268B2Feb 24, 2015
Method for determining survival prognosis of patients suffering from non-small cell lung cancer (NSCLC)
DE WIJN RICHARD1 citations44